Subscribe Login

FDA E-Cigarette Ruling 'Credit Positive' For Sector, Says Moody's

By Steve Wynne-Jones
Share this article
FDA E-Cigarette Ruling 'Credit Positive' For Sector, Says Moody's

The decision by the US Food and Drug Administration (FDA) to ban certain flavoured e-cigarette cartridges, subject to them being cleared by the FDA's premarket tobacco application (PMTA) process, is a 'credit positive' move in the long term for the tobacco sector, Moody's has said.

In a sector comment, Moody's noted that the ban is likely to have 'no immediate effect' on the credit quality of the tobacco companies it rates, either because they had already removed these products from sale in anticipation of the FDA's decision, or because they do not sell these products.

Regulatory Clarity


30 Day Free Trial

Try European Supermarket Magazine Premium

Enjoy full access to European Supermarket Magazine, our weekly
email news digest, access to all website and app content, and the latest digital
magazine for a full 30 days.

  • - Payment details required during trial sign up.
  • - You may cancel at any time up to the end of the 30-day trial period.
  • - If you continue after the trial perion, then the annual rate of €109+VAT will be debited.
Get the week's top grocery retail news

The most important stories from European grocery retail direct to your inbox every Thursday

Processing your request...

Thanks! please check your email to confirm your subscription.

By signing up you are agreeing to our terms & conditions and privacy policy. You can unsubscribe at any time.